Repligen (RGEN) Insider Trading & Ownership $144.46 -2.08 (-1.42%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Repligen (NASDAQ:RGEN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.20%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$449,938.10Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$12.38 M Get RGEN Insider Trade Alerts Want to know when executives and insiders are buying or selling Repligen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RGEN Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Repligen Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/10/2024Anthony HuntDirectorSell22,191$145.37$3,225,905.67 8/1/2024Ralf KuriyelVPSell4,465$165.67$739,716.55 6/14/2024Anthony HuntCEOBuy2,000$124.08$248,160.00 6/14/2024Martin D MadausDirectorBuy1,615$124.94$201,778.10 5/21/2024Anthony HuntCEOSell20,072$168.26$3,377,314.72 3/11/2024Ralf KuriyelVPSell3,517$193.73$681,348.41 3/8/2024Anthony HuntCEOSell16,707$197.44$3,298,630.08 2/27/2024Karen A DawesDirectorSell1,000$193.35$193,350.00 2/23/2024James BylundCOOSell4,373$198.08$866,203.84 (Data available from 1/1/2013 forward) RGEN Insider Trading Activity - Frequently Asked Questions Who is on Repligen's Insider Roster? The list of insiders at Repligen includes Anthony Hunt, Christine Gebski, James Bylund, Jon Snodgres, Karen A Dawes, Manner Carrie Eglinton, Martin D Madaus, Ralf Kuriyel, and Thomas F Ryan Jr. Learn more on insiders at RGEN. What percentage of Repligen stock is owned by insiders? 1.20% of Repligen stock is owned by insiders. Learn more on RGEN's insider holdings. Which Repligen insiders have been buying company stock? The following insiders have purchased RGEN shares in the last 24 months: Anthony Hunt ($248,160.00), and Martin D Madaus ($360,443.10). How much insider buying is happening at Repligen? Insiders have purchased a total of 4,615 RGEN shares in the last 24 months for a total of $608,603.10 bought. Which Repligen insiders have been selling company stock? The following insiders have sold RGEN shares in the last 24 months: Anthony Hunt ($9,901,850.47), Christine Gebski ($557,328.44), James Bylund ($866,203.84), Karen A Dawes ($339,023.00), and Ralf Kuriyel ($1,421,064.96). How much insider selling is happening at Repligen? Insiders have sold a total of 76,963 Repligen shares in the last 24 months for a total of $13,085,470.71 sold. Repligen Key ExecutivesMr. Anthony J. Hunt (Age 60)Executive Chair Compensation: $885k1 recent tradesMr. Olivier Loeillot (Age 54)President, CEO & Director Compensation: $1.49MMr. Jason K. Garland (Age 50)CFO & Chief Compliance Officer Compensation: $282.99kMr. James R. Bylund (Age 60)Chief Operating Officer Compensation: $472.18kMr. Ralf Kuriyel (Age 66)Senior Vice President of Research & Development Compensation: $401.74k1 recent tradesMr. Keith Lee RobinsonChief Information OfficerMs. Sondra S. NewmanGlobal Head of Investor RelationsMs. Kimberly A. CornwellGlobal Head of LegalMr. Neil WhitfieldVP & Global Head of SalesMs. Leslie GalvinVice President of Human Resources More Insider Trading Tools from MarketBeat Related Companies Alnylam Pharmaceuticals Insider Trades Biogen Insider Trades United Therapeutics Insider Trades Neurocrine Biosciences Insider Trades Incyte Insider Trades BioMarin Pharmaceutical Insider Trades Exact Sciences Insider Trades Exelixis Insider Trades Madrigal Pharmaceuticals Insider Trades Halozyme Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:RGEN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
